A Multi-National, Multi-Center Non-Interventional Study in Rheumatoid Arthritis (RA) Patients Treated With Tocilizumab
Phase of Trial: Phase IV
Latest Information Update: 03 Aug 2017
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Roche
- 31 Aug 2018 Biomarkers information updated
- 07 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Feb 2014 Planned End Date changed from 1 Dec 2013 to 1 Feb 2014 as reported by ClinicalTrials.gov.